BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,152,108 | -17.1% | 1,045,763 | -10.4% | 0.02% | -16.7% |
| Q2 2023 | $53,251,246 | -30.3% | 1,167,279 | -21.2% | 0.02% | -45.5% |
| Q4 2022 | $76,407,036 | -33.6% | 1,481,905 | -22.4% | 0.03% | -34.0% |
| Q3 2022 | $115,148,000 | +3.9% | 1,909,565 | +26.3% | 0.05% | -2.0% |
| Q2 2022 | $110,780,000 | +4.6% | 1,511,336 | +13.3% | 0.05% | 0.0% |
| Q1 2022 | $105,865,000 | -16.3% | 1,333,475 | -8.9% | 0.05% | -23.9% |
| Q4 2021 | $126,525,000 | -37.8% | 1,463,043 | -41.1% | 0.07% | -28.0% |
| Q3 2021 | $203,400,000 | +24.4% | 2,483,504 | +24.4% | 0.09% | +14.8% |
| Q2 2021 | $163,496,000 | +19.0% | 1,996,789 | +22.1% | 0.08% | -9.0% |
| Q1 2021 | $137,413,000 | +4.5% | 1,635,864 | +2.6% | 0.09% | +2.3% |
| Q4 2020 | $131,484,000 | -13.1% | 1,594,334 | -15.2% | 0.09% | -31.0% |
| Q3 2020 | $151,329,000 | -5.4% | 1,880,791 | +0.8% | 0.13% | -13.7% |
| Q2 2020 | $159,889,000 | -1.4% | 1,865,888 | -5.4% | 0.15% | -21.5% |
| Q1 2020 | $162,127,000 | -15.6% | 1,971,853 | -14.1% | 0.19% | +29.2% |
| Q4 2019 | $192,020,000 | +33.8% | 2,296,345 | +40.0% | 0.14% | +16.1% |
| Q3 2019 | $143,471,000 | +210.8% | 1,640,239 | +191.0% | 0.12% | +217.9% |
| Q2 2019 | $46,162,000 | -3.9% | 563,629 | -4.6% | 0.04% | -4.9% |
| Q1 2019 | $48,022,000 | +35.1% | 590,597 | +9.4% | 0.04% | +20.6% |
| Q4 2018 | $35,533,000 | -34.4% | 539,842 | -23.1% | 0.03% | -19.0% |
| Q3 2018 | $54,144,000 | +22.3% | 702,345 | +17.2% | 0.04% | +13.5% |
| Q2 2018 | $44,264,000 | -3.8% | 599,485 | -15.3% | 0.04% | -9.8% |
| Q1 2018 | $46,005,000 | -55.2% | 707,368 | -55.5% | 0.04% | -53.9% |
| Q4 2017 | $102,696,000 | -11.8% | 1,588,725 | -14.4% | 0.09% | -16.8% |
| Q3 2017 | $116,442,000 | +16.2% | 1,855,629 | +12.1% | 0.11% | +11.5% |
| Q2 2017 | $100,220,000 | +241.6% | 1,655,432 | +192.7% | 0.10% | +242.9% |
| Q1 2017 | $29,335,000 | +24.1% | 565,665 | +6.2% | 0.03% | +12.0% |
| Q4 2016 | $23,637,000 | -61.5% | 532,750 | -58.6% | 0.02% | -62.7% |
| Q3 2016 | $61,326,000 | +129.4% | 1,288,351 | +118.0% | 0.07% | +116.1% |
| Q2 2016 | $26,731,000 | +18.6% | 591,113 | +7.7% | 0.03% | +29.2% |
| Q1 2016 | $22,538,000 | +1.3% | 548,622 | -5.9% | 0.02% | -11.1% |
| Q4 2015 | $22,251,000 | +27.9% | 583,268 | +10.1% | 0.03% | +12.5% |
| Q3 2015 | $17,399,000 | -69.0% | 529,697 | -34.0% | 0.02% | -63.6% |
| Q2 2015 | $56,153,000 | +4.5% | 803,003 | +2.3% | 0.07% | +6.5% |
| Q1 2015 | $53,747,000 | -13.8% | 784,598 | -7.7% | 0.06% | -12.7% |
| Q4 2014 | $62,320,000 | -3.4% | 850,317 | -5.4% | 0.07% | -2.7% |
| Q3 2014 | $64,486,000 | -0.4% | 898,509 | +0.4% | 0.07% | +1.4% |
| Q2 2014 | $64,713,000 | +23.7% | 895,089 | +25.9% | 0.07% | +5.9% |
| Q1 2014 | $52,328,000 | +24.3% | 711,165 | +17.5% | 0.07% | +17.2% |
| Q4 2013 | $42,100,000 | +8.8% | 605,317 | +2.7% | 0.06% | -3.3% |
| Q3 2013 | $38,706,000 | +30.2% | 589,212 | +37.3% | 0.06% | +13.2% |
| Q2 2013 | $29,720,000 | – | 429,038 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |